Physician profile
Juhi Bhatt
NPI 1477195212
$1,064.51
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,065.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $131.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $93.43 | 2021 | |
| Abbvie INC. | $92.87 | 2021 | |
| Amgen INC. | $91.90 | 2021 | |
| Merck Sharp & Dohme LLC | $77.56 | 2021 | |
| Horizon Therapeutics Plc | $70.83 | 2021 | |
| Jazz Pharmaceuticals INC. | $57.81 | 2021 | |
| Glaxosmithkline, LLC. | $53.27 | 2021 | |
| Amarin Pharma, INC. | $51.54 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.27 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.56 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $41.13 | 2021 | |
| Lilly USA, LLC | $33.64 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.31 | 2021 | |
| Evoke Pharma, INC. | $26.79 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $26.52 | 2021 | |
| Alkermes, INC. | $21.63 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.31 | 2021 | |
| Eisai INC. | $15.51 | 2021 | |
| Endo Pharmaceuticals INC. | $13.38 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.26 | 2021 | |
| Pfizer INC. | $12.17 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juhi Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.